Search
(3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium
go.drugbank.com/drugs/DB02648ExperimentalIt is used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyperlipoproteinemias. [PubChem]
Synonyms: (3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-AmmoniumAsiatic acid
go.drugbank.com/drugs/DB14054InvestigationalFrom Centella asiatica and other plants; shows a variety of bioactivities.
Mixtures: Karatica Im Cica Essence PackPhenamazoline
go.drugbank.com/drugs/DB19509ExperimentalPhenamazoline is a small molecule drug. The usage of the INN stem '-azoline' in the name indicates that Phenamazoline is a antihistaminic or local vasoconstrictor, antazoline derivative.
Tinazoline
go.drugbank.com/drugs/DB20310ExperimentalTinazoline is a small molecule drug. The usage of the INN stem '-azoline' in the name indicates that Tinazoline is a antihistaminic or local vasoconstrictor, antazoline derivative.
Nemazoline
go.drugbank.com/drugs/DB21115ExperimentalNemazoline is a small molecule drug. The usage of the INN stem '-azoline' in the name indicates that Nemazoline is a antihistaminic or local vasoconstrictor, antazoline derivative.
Dimenoxadol
go.drugbank.com/drugs/DB01461ExperimentalIllicitIn the United States it is classified as a Schedule I controlled drug. … Dimenoxadol is an opioid analgesic which produces typical opioid effects such as analgesia and sedation. It is structurally similar to methadone and is a benzilic acid derivative.
Aniracetam
go.drugbank.com/drugs/DB04599InvestigationalCompound with anti-depressive properties used as a mental performance enhancer.
Categories: Psychostimulants, Agents Used for ADHD and NootropicsAganepag isopropyl
go.drugbank.com/drugs/DB16085InvestigationalAganepag isopropyl is under investigation in clinical trial NCT01110499 (Safety and Efficacy of AGN-210961 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Glaucoma or
D3S-001
go.drugbank.com/drugs/DB19008InvestigationalD3S-001 is under investigation in clinical trial NCT05410145 (A Study of D3S 001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.g12c Mutation).